These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26461463)

  • 21. Prednisone Pharmacokinetics During Pregnancy and Lactation.
    Ryu RJ; Easterling TR; Caritis SN; Venkataramanan R; Umans JG; Ahmed MS; Clark S; Kantrowitz-Gordon I; Hays K; Bennett B; Honaker MT; Thummel KE; Shen DD; Hebert MF
    J Clin Pharmacol; 2018 Sep; 58(9):1223-1232. PubMed ID: 29733485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug.
    Qian J; Xu T; Pan P; Sun W; Hu G; Cai J
    Pharmacogenomics J; 2024 Apr; 24(3):13. PubMed ID: 38637522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of metoprolol metabolism and potentiation of its effects by paroxetine in routinely treated patients with acute myocardial infarction (AMI).
    Goryachkina K; Burbello A; Boldueva S; Babak S; Bergman U; Bertilsson L
    Eur J Clin Pharmacol; 2008 Mar; 64(3):275-82. PubMed ID: 18043911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enantioselective determination of metoprolol acidic metabolite in plasma and urine using liquid chromatography chiral columns: applications to pharmacokinetics.
    Cerqueira PM; Boralli VB; Coelho EB; Lopes NP; Guimarães LF; Bonato PS; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(2):433-41. PubMed ID: 12482486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
    Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M
    Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol.
    Nozawa T; Taguchi M; Tahara K; Hashimoto Y; Igarashi N; Nonomura M; Kato B; Igawa A; Inoue H
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):713-20. PubMed ID: 16220080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of chronic renal failure on stereoselective metoprolol metabolism in hypertensive patients.
    Cerqueira PM; Coelho EB; Geleilete TJ; Goldman GH; Lanchote VL
    J Clin Pharmacol; 2005 Dec; 45(12):1422-33. PubMed ID: 16291718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?
    Ohman I; Vitols S; Tomson T
    Epilepsia; 2005 Oct; 46(10):1621-4. PubMed ID: 16190933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous determination of metoprolol and its metabolites, α-hydroxymetoprolol and O-desmethylmetoprolol, in human plasma by liquid chromatography with tandem mass spectrometry: Application to the pharmacokinetics of metoprolol associated with CYP2D6 genotypes.
    Bae SH; Lee JK; Cho DY; Bae SK
    J Sep Sci; 2014 Jun; 37(11):1256-64. PubMed ID: 24648255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects.
    Wuttke H; Rau T; Heide R; Bergmann K; Böhm M; Weil J; Werner D; Eschenhagen T
    Clin Pharmacol Ther; 2002 Oct; 72(4):429-37. PubMed ID: 12386645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disposition of the adrenergic blocker metoprolol in the late pregnant women, the amniotic fluid, the cord blood and the neonate.
    Sandström B; Lindeberg S; Lundborg P; Regårdh CG
    Clin Exp Hypertens B; 1983; 2(1):75-82. PubMed ID: 6135523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine.
    Stout SM; Nielsen J; Welage LS; Shea M; Brook R; Kerber K; Bleske BE
    J Clin Pharmacol; 2011 Mar; 51(3):389-96. PubMed ID: 20400652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype.
    Kaila N; Straka RJ; Brundage RC
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):141-56. PubMed ID: 17053980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective metabolism of metoprolol: enantioselectivity of alpha-hydroxymetoprolol in plasma and urine.
    Cerqueira PM; Cesarino EJ; Bertucci C; Bonato PS; Lanchote VL
    Chirality; 2003 Jun; 15(6):542-9. PubMed ID: 12774293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in pancreatic B cell function during late pregnancy, early lactation and postlactation.
    Hubinont CJ; Balasse H; Dufrane SP; Leclercq-Meyer V; Sugar J; Schwers J; Malaisse WJ
    Gynecol Obstet Invest; 1988; 25(2):89-95. PubMed ID: 3286394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valdecoxib does not interfere with the CYP2D6 substrate metoprolol.
    Werner U; Lamprecht C; Werner D; Schaefer S; Wuttke H; Hinz B; Fromm MF; Brune K
    Int J Clin Pharmacol Ther; 2006 Sep; 44(9):397-400. PubMed ID: 16995327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rationale and methods of the UNAMET study (dose- and CYP2D6-genotype-dependent adverse drug reactions of metoprolol)--a contribution to quality improvement in pharmacotherapy].
    Fux R; Meisner C; Schwab M; Lorenz G; Mörike K; Gleiter CH
    Z Arztl Fortbild Qualitatssich; 2004 Nov; 98(8):689-94. PubMed ID: 15646732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of amlodipine besylate at delivery and during lactation.
    Morgan JL; Kogutt BK; Meek C; Stehel EK; McIntire DD; Sheffield JS; Roberts SW
    Pregnancy Hypertens; 2018 Jan; 11():77-80. PubMed ID: 29523279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.